December 21, 2022 | Kinna Thakarar, DO, MPH Learning objectives: Recognize the interplay between Infectious Disease and Substance Use disorder epidemics Identify opportunities to incorporate recommended screening into practice settings
November 30, 2022 | Kinna Thakarar
Learning objectives:
Review harm reduction approaches
Understand the roles of syringe service programs
Understand how to incorporate harm reduction principles in your current work with people who use drugs
December 6, 2022 | Kevin M. Gray, M.D., Professor of Psychiatry and Behavioral Sciences, Medical University of South Carolina Dr. Gray will provide a general overview of the complex and evolving context for cannabis use. The talk will then focus on cannabis use disorder (CUD) and its clinical implications. An overview of evidence-based psychosocial strategies …
Cannabis and Cannabis Use Disorder: Updates for Clinicians on a Complex Topic Read More »
December 12, 2022 | Dr. Alane O’Connor, DNP Urine toxicology testing can be a useful tool in clinical decision making when caring for patients with substance use disorders. It is critical for providers to be familiar with the pros and cons of various types of testing and to be skilled in interpreting the results. Objectives: …
Urine Toxicology Testing in Substance Use Disorder Treatment Read More »
Diagnosis and Treatment of ADHD in Adults with Substance Use Disorder: Applying Evidence to a Common Clinical Quandary | November 10, 2022 | Andrea Truncali, Lauren Moran, and Margaret Chaplin
Diagnosis and treatment of adult ADHD is on the rise. Patients with substance use disorder are thought to be disproportionately affected by ADHD but how safe is, and what impact does the pharmacologic treatment have?
November 3, 2022 | Jonathan C Fellers, MD
Learning objectives:
Understand the pharmacologic differences between buprenorphine and methadone
Describe 2 strategies for switching between buprenorphine and methadone
Discuss informed consent and considerations for patients
November 14, 2022 | Ben Townsend and Elisabeth Fowlie Mock
This program will review current legal requirements for Maine opioid prescribers and the possible effects of current law enforcement activity
November 9, 2022 | Eric Haram, LADC
Universal screening and brief intervention and referral for substance misuse within primary care settings is a foundation activity soon to be required under PCPlus. This program will review the nuts and bolts to help providers implement this evidence-based practice. Screening tools to be highlighted include CRAFFT, DAST, AUDIT, 4Ps.
